Tw. Stephens et Jf. Caro, TO BE LEAN OR NOT TO BE LEAN - IS LEPTIN THE ANSWER, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(1), 1998, pp. 1-15
Leptin and the leptin receptor genes have been identified as the site
of mutations in the peripheral adipocyte hormone pathway responsible f
or obesity in the ob/ob mouse (Zhang et al., 1994) and the db/db mouse
(Chen et al., 1996). In obese humans, ob/ob like mutations in leptin
are rare but confirm a role for leptin (Montague et al., 1997), and db
/db like mutations in the leptin receptor have not been found (Considi
ne et al., 1996a); however, the increased understanding of the molecul
ar basis for obesity has generated tremendous interest among scientist
s and patients alike. The new knowledge could be the base for intellig
ent drugs for the treatment of obesity. Herein we will put in perspect
ive a) the physiological background that led to the discovery of lepti
n, b) leptin biosynthesis, c) leptin action and d) the clinical issues
related to leptin as a drug for the treatment of obesity.